What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
Lyophilised (freeze-dried) peptides
Again, this can influence the optimal treatment programme for your Achilles tendon
5-Amino-1MQ Peptides, presented in lyophilized powder form, should be stored in a cool, dry environment to maintain their stability
This reaction, while uncomfortable, typically resolves with proper management and doesnt indicate treatment failure
Safety and tolerability of the hexadecapeptide AOD9604 in humans